NovaBridge Biosciences (NBP) Income Statement: Revenue & Earnings

NovaBridge Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scale:

Scroll to see more

NovaBridge Biosciences income statement - Annual data in billions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.09	0.24
Cost of Revenue	0.00	0.00	0.00	-0.05	0.00
Gross Profit	0.00	0.00	-0.04	0.04	0.24
Operating Expenses
Research & Development	0.02	0.02	0.02	1.21	0.15
Selling, General & Administrative	0.03	0.03	0.03	0.90	0.06
Operating Expenses	0.05	0.05	0.05	2.11	0.21
Operating Income	-0.05	-0.05	-0.05	-2.07	0.02
Other Income/Expense
Interest Income	0.01	0.01	0.00	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	0.00	0.00	-0.09	0.28	0.00
Income
Income Before Tax	-0.05	-0.08	-0.14	-2.33	0.07
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-0.02	-0.21	-0.37	-2.33	0.07
Net Income - Continuous Operations	-0.05	-0.08	-0.14	-0.37	0.00
Net Income - Discontinued Operations	0.03	-0.13	-0.23	0.00	0.00
EBITDA	-0.05	-0.05	-0.05	-2.33	0.03
EBIT	-0.05	-0.05	-0.05	-2.33	0.02
Depreciation & Amortization	0.00	0.00	0.00	-0.01	0.00
Earnings Per Share
Basic EPS	-	-2.00	-4.00	-13.00	1.00
Diluted EPS	-	-2.00	-4.00	-13.00	1.00
Basic Shares Outstanding	0.08	0.08	0.08	0.17	0.06
Diluted Shares Outstanding	0.08	0.08	0.08	0.17	0.07